121 related articles for article (PubMed ID: 11177451)
1. Injecting drug users' adherence to HIV antiretroviral treatments: physicians' beliefs.
Escaffre N; Morin M; Bouhnik AD; Fuzibet JG; Gastaut JA; Obadia Y; Moatti JP;
AIDS Care; 2000 Dec; 12(6):723-30. PubMed ID: 11177451
[TBL] [Abstract][Full Text] [Related]
2. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
[TBL] [Abstract][Full Text] [Related]
3. Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8).
Carrieri MP; Villes V; Raffi F; Protopopescu C; Preau M; Salmon D; Taieb A; Lang JM; Verdon R; Chene G; Spire B;
Int J Drug Policy; 2007 Aug; 18(4):288-95. PubMed ID: 17689377
[TBL] [Abstract][Full Text] [Related]
4. Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union.
Wolfe D
Int J Drug Policy; 2007 Aug; 18(4):246-54. PubMed ID: 17689372
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
6. A cohort study of drug users' compliance with zidovudine treatment.
Broers B; Morabia A; Hirschel B
Arch Intern Med; 1994 May; 154(10):1121-7. PubMed ID: 8185425
[TBL] [Abstract][Full Text] [Related]
7. Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment.
Sharma M; Singh RR; Laishram P; Kumar B; Nanao H; Sharma C; Ahmed T
Int J Drug Policy; 2007 Aug; 18(4):319-25. PubMed ID: 17689381
[TBL] [Abstract][Full Text] [Related]
8. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
[TBL] [Abstract][Full Text] [Related]
9. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group.
Carrieri MP; Moatti JP; Vlahov D; Obadia Y; Reynaud-Maurupt C; Chesney M
J Epidemiol Community Health; 1999 Jan; 53(1):4-8. PubMed ID: 10326045
[TBL] [Abstract][Full Text] [Related]
10. Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.
Larsen MV; Omland LH; Gerstoft J; Larsen CS; Jensen J; Obel N; Kronborg G
Addiction; 2010 Mar; 105(3):529-35. PubMed ID: 20402997
[TBL] [Abstract][Full Text] [Related]
11. Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users.
Ding L; Landon BE; Wilson IB; Wong MD; Shapiro MF; Cleary PD
Arch Intern Med; 2005 Mar; 165(6):618-23. PubMed ID: 15795336
[TBL] [Abstract][Full Text] [Related]
12. Health related quality of life among both current and former injection drug users who are HIV-infected.
Préau M; Protopopescu C; Spire B; Sobel A; Dellamonica P; Moatti JP; Carrieri MP;
Drug Alcohol Depend; 2007 Jan; 86(2-3):175-82. PubMed ID: 16930864
[TBL] [Abstract][Full Text] [Related]
13. Sexual behaviour of women living with HIV/AIDS naïve for antiretroviral therapy: the ICONA-BEHEPI Study.
Aloisi MS; Serraino D; Girardi E; Lauria FN; D'Arminio Monforte A; Cargnel A; Bonazzi L; Petrosillo N; Abrescia N; Mazzotta F; Vullo V; Ferraro T; Suter F; Masi A; Rezza G; Ippolito G;
AIDS Care; 2000 Dec; 12(6):789-95. PubMed ID: 11177458
[TBL] [Abstract][Full Text] [Related]
14. Physicians' and patients' adherence to antiretroviral prophylaxis after sexual exposure to HIV: results from South-Eastern France.
Rey D; Bendiane MK; Bouhnik AD; Almeda J; Moatti JP; Carrieri MP
AIDS Care; 2008 May; 20(5):537-41. PubMed ID: 18484321
[TBL] [Abstract][Full Text] [Related]
15. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
[TBL] [Abstract][Full Text] [Related]
16. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
[TBL] [Abstract][Full Text] [Related]
17. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.
Fumaz CR; Muñoz-Moreno JA; Moltó J; Ferrer MJ; López-Blázquez R; Negredo E; Paredes R; Gómez G; Clotet B
AIDS Care; 2008 Aug; 20(7):796-805. PubMed ID: 18728987
[TBL] [Abstract][Full Text] [Related]
18. The opinions of injecting drug user (IDUs) HIV patients and health professionals on access to antiretroviral treatment and health services in Valencia, Spain.
Garcia de la Hera M; Davo MC; Ballester-Añón R; Vioque J
Eval Health Prof; 2011 Sep; 34(3):349-61. PubMed ID: 21411470
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
[TBL] [Abstract][Full Text] [Related]
20. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
